Saudi Advisory Group For Pulmonary Hypertension and Pulmonary Vascular Research Institute

Hyatt Regency Casablanca Place des Nations Unies, Casablanca, Morocco 20000 17-20 February 2009

1.       Magdi Yacoub – UK

Historical Lecture: Lung Transplant for Pulmonary Hypertension

2.       Robyn Barst – USA (PVRI)

·         Pediatric IPAH: what is so special?

3.       Majdy Idrees – KSA (SAPH/PVRI)

·       Highlights from the Saudi guidelines on the diagnosis and treatment of PAH

·       The role of inhaled Iloprost in sub-massive pulmonary embolism

4.       Paul Hassoun – USA (PVRI)

·       The role of inflammation in PAH: cause or consequence?

5.       Duncan Stewart – Canada (PVRI)

·       Vascular remodeling in PAH: chance for reversibility?

6.       Rubin Tuder – USA (PVRI)

·       The diseased endothelium: would it explain it all?

7.       Rolf Berger – Netherland (PVRI)

·       PAH in children with congenital heart disease

8.       Antonio Lopes – Brazil (PVRI)

·       PAH in adults with congenital heart disease (the Eisenmenger syndrome)

9.       Sarfraz Saleemi – KSA (SAPH)

·       Chronic thromboembolic pulmonary hypertension

10.    Ghazwan Butrous – UK (PVRI)

·         PH secondary to Schistosomiasis

·         The malignant nature of PAH

11.    Ayman Krayem – KSA (SAPH)

·         PH in sleep breathing disorders

12.    Omar Minai – USA (PVRI)

·         PH in COPD/ILD

·         Peri-operative risks for PH patients

13.    Saleh Dammas – KSA (SAPH)

·         Portopulmonary hypertension

14.    Jean-Paul Richalet – France (PVRI)

·         PH and Monge's disease

15.    H Ardeschir Ghofrani – Germany (PVRI)

·         Non PAH PH: rationale approach to Rx strategies

·         Pharmacological management: Where are we standing?

·         Soluble guanylyl cyclise activator – future studies

16.    Stephen Archer – USA (PVRI)

·         Metabolic and ionic remodeling in the RV in RVH

17.    Andrew Peacock – UK (PVRI)

·         Imaging the right ventricle in pulmonary hypertension

18.    Tarek Kashour – KSA (SAPH)

·         Management of acute RV failure in chronic PAH

·         Case presentation

19.    Raed Dweik – USA (PVRI)

·         The role of biomarkers in the diagnosis and management of PAH

·         PAH target treatment: Start early or late?

20.    Hunter Champion – USA (PVRI)

·         RV in IPAH versus scleroderma-related PAH

·         Pathophysiological abnormalities of exercise in PAH

21.    Ali Alazem – KSA (SAPH)

·         Management of acute PH in the ICU

22.    Roberto Machado – USA (PVRI)

§     PH secondary to sickle cell disease and other hemoglobinopathy

23.    Nicola Petrosillo – Italy (PVRI)

·         PH secondary to HIV

Registration Form and Hotel booking